{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:33:42Z","timestamp":1791063222305,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,22]],"date-time":"2012-04-22T00:00:00Z","timestamp":1335052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s12031-012-9778-5","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T05:47:22Z","timestamp":1334987242000},"page":"514-518","source":"Crossref","is-referenced-by-count":16,"title":["An Intronic CYP46A1 Polymorphism Is Associated with Alzheimer Disease in a Chinese Han Population"],"prefix":"10.1007","volume":"47","author":[{"given":"Xiao-ming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mou-ni","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,22]]},"reference":[{"key":"9778_CR1","first-page":"351","volume":"25","author":"D Antoniades","year":"2011","unstructured":"Antoniades D, Katopodi T, Pappa S, Lampropoulos A, Konsta V, Frydas E, Mpalogiannis S, Hatzistilianou M (2011) The role of reelin gene polymorphisms in the pathogenesis of Alzheimer\u2019s disease in a Greek population. J Biol Regul Homeost Agents 25:351\u2013358","journal-title":"J Biol Regul Homeost Agents"},{"key":"9778_CR2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neurobiolaging.2003.08.004","volume":"25","author":"B Borroni","year":"2004","unstructured":"Borroni B, Archetti S, Agosti C, Akkawi N, Brambilla C, Caimi L, Caltagirone C, Di Luca M, Padovani A (2004) Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging 25:747\u2013751","journal-title":"Neurobiol Aging"},{"key":"9778_CR3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","volume":"65","author":"D Campion","year":"1999","unstructured":"Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A, Martin C, Charbonnier F, Raux G, Camuzat A, Penet C, Mesnage V, Martinez M, Clerget-Darpoux F, Brice A, Frebourg T (1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65:664\u2013670","journal-title":"Am J Hum Genet"},{"key":"9778_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00001756-200401190-00019","volume":"15","author":"KA Chalmers","year":"2004","unstructured":"Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S (2004) APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer\u2019s disease. Neuroreport 15:95\u201398","journal-title":"Neuroreport"},{"key":"9778_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000080025","volume":"18","author":"O Combarros","year":"2004","unstructured":"Combarros O, Infante J, Llorca J, Berciano J (2004) Genetic association of CYP46 and risk for Alzheimer\u2019s disease. Dement Geriatr Cog Disord 18:257\u2013260","journal-title":"Dement Geriatr Cog Disord"},{"key":"9778_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(02)00443-3","volume":"328","author":"P Desai","year":"2002","unstructured":"Desai P, DeKosky ST, Kamboh MI (2002) Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer\u2019s disease. Neurosci Lett 328:9\u201312","journal-title":"Neurosci Lett"},{"key":"9778_CR7","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","volume":"98","author":"K Fassbender","year":"2001","unstructured":"Fassbender K, Simons M, Bergmann C, Stroick M, L\u00fctjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmann K, Hennerici M, Beyreuther K, Hartmann T (2001) Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A 98:5856\u20135861","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9778_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000090215","volume":"21","author":"V Fern\u00e1ndez Del Pozo","year":"2006","unstructured":"Fern\u00e1ndez Del Pozo V, Alvarez Alvarez M, Fern\u00e1ndez Mart\u00ednez M, Gald\u00f3s Alcelay L, G\u00f3mez Busto F, Pe\u00f1a JA, Alfonso-S\u00e1nchez MA, Zarranz Imirizaldu JJ, de Pancorbo MM (2006) Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer\u2019s disease and of mild cognitive impairment progressing to Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 21:81\u201387","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9778_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2005.03.049","volume":"383","author":"E Golanska","year":"2005","unstructured":"Golanska E, Hulas-Bigoszewska K, Wojcik I, Rieske P, Styczynska M, Peplonska B, Pfeffer A, Luczywek E, Wasiak B, Gabryelewicz T, Religa D, Chodakowska-Zebrowska M, Barcikowska M, Sobow T, Liberski PP (2005) CYP46: a risk factor for Alzheimer\u2019s disease or a coincidence? Neurosci Lett 383:105\u2013108","journal-title":"Neurosci Lett"},{"key":"9778_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jnnp.2005.071928","volume":"77","author":"S Helisalmi","year":"2006","unstructured":"Helisalmi S, Veps\u00e4l\u00e4inen S, Koivisto AM, Mannermaa A, Iivonen S, Hiltunen M, Kiviniemi V, Soininen H (2006) Association of CYP46 intron 2 polymorphism in Finnish Alzheimer\u2019s disease samples and a global scale summary. J Neurol Neurosurg Psychiatry 77:421\u2013422","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9778_CR11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/JMN:23:3:189","volume":"23","author":"Y Huang","year":"2004","unstructured":"Huang Y, Weisgraber KH, Mucke L, Mahley RW (2004) Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer\u2019s disease. J Mol Neurosci 23:189\u2013204","journal-title":"J Mol Neurosci"},{"key":"9778_CR12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neulet.2004.06.011","volume":"367","author":"M Ingelsson","year":"2004","unstructured":"Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW (2004) Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer\u2019s disease. Neurosci Lett 367:228\u2013231","journal-title":"Neurosci Lett"},{"key":"9778_CR13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00439-004-1107-9","volume":"114","author":"A Johansson","year":"2004","unstructured":"Johansson A, Katzov H, Zetterberg H, Feuk L, Johansson B, Bogdanovic N, Andreasen N, Lenhard B, Brookes AJ, Pedersen NL, Blennow K, Prince JA (2004) Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer\u2019s disease. Hum Genet 114:581\u2013587","journal-title":"Hum Genet"},{"key":"9778_CR14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s11064-005-5979-4","volume":"30","author":"A Juh\u00e1sz","year":"2005","unstructured":"Juh\u00e1sz A, Riman\u00f3czy A, Boda K, Vincze G, Szl\u00e1vik G, Zana M, Bjelik A, P\u00e1k\u00e1ski M, B\u00f3di N, Palot\u00e1s A, Janka Z, K\u00e1lm\u00e1n J (2005) CYP46 T\/C polymorphism is not associated with Alzheimer\u2019s dementia in a population from Hungary. Neurochem Res 30:943\u2013948","journal-title":"Neurochem Res"},{"key":"9778_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2004.03.066","volume":"363","author":"A Kabbara","year":"2004","unstructured":"Kabbara A, Payet N, Cottel D, Frigard B, Amouyel P, Lambert JC (2004) Exclusion of CYP46 and APOM as candidate genes for Alzheimer\u2019s disease in a French population. Neurosci Lett 363:139\u2013143","journal-title":"Neurosci Lett"},{"issue":"Suppl 2","key":"9778_CR16","first-page":"S113","volume":"36","author":"C Kirsch","year":"2003","unstructured":"Kirsch C, Eckert GP, Koudinov AR, M\u00fcller WE (2003) Brain cholesterol, statins and Alzheimer\u2019s disease. Pharmacopsychiatry 36(Suppl 2):S113\u2013S119","journal-title":"Pharmacopsychiatry"},{"key":"9778_CR17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eurpsy.2008.12.005","volume":"24","author":"H K\u00f6lsch","year":"2009","unstructured":"K\u00f6lsch H, L\u00fctjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Schmitz S, Maier W, Heun R (2009) CYP46A1 variants influence Alzheimer\u2019s disease risk and brain cholesterol metabolism. Eur Psychiatry 24:183\u2013190","journal-title":"Eur Psychiatry"},{"key":"9778_CR18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.mp.4001109","volume":"7","author":"H K\u00f6lsch","year":"2002","unstructured":"K\u00f6lsch H, L\u00fctjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R (2002) Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer\u2019s disease. Mol Psychiatry 7:899\u2013902","journal-title":"Mol Psychiatry"},{"key":"9778_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000095723","volume":"22","author":"Y Li","year":"2006","unstructured":"Li Y, Chu LW, Chen YQ, Cheung BM, Leung RY, Yik PY, Ng KM, Mak W, Jin DY, St George-Hyslop P, Song YQ (2006) Intron 2 (T\/C) CYP46 polymorphism is associated with Alzheimer\u2019s disease in Chinese patients. Dement Geriatr Cogn Disord 22:399\u2013404","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9778_CR20","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","volume":"96","author":"EG Lund","year":"1999","unstructured":"Lund EG, Guileyardo JM, Russell DW (1999) cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A 96:7238\u20137243","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"9778_CR21","first-page":"S102","volume":"36","author":"D L\u00fctjohann","year":"2003","unstructured":"L\u00fctjohann D, von Bergmann K (2003) 24S-hydroxycholesterol: a marker of brain cholesterol metabolism. Pharmacopsychiatry 36(Suppl 2):S102\u2013S106","journal-title":"Pharmacopsychiatry"},{"key":"9778_CR22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S1041610205003108","volume":"18","author":"SL Ma","year":"2006","unstructured":"Ma SL, Tang NL, Lam LC, Chiu HF (2006) Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer\u2019s disease in a Chinese population. Int Psychogeriatr 18:37\u201345","journal-title":"Int Psychogeriatr"},{"key":"9778_CR23","doi-asserted-by":"crossref","first-page":"14284","DOI":"10.1021\/bi035512f","volume":"42","author":"N Mast","year":"2003","unstructured":"Mast N, Norcross R, Andersson U, Shou M, Nakayama K, Bjorkhem I, Pikuleva IA (2003) Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. Biochemistry 42:14284\u201314292","journal-title":"Biochemistry"},{"key":"9778_CR24","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00001756-200006260-00030","volume":"11","author":"A Papassotiropoulos","year":"2000","unstructured":"Papassotiropoulos A, L\u00fctjohann D, Bagli M, Locatelli S, Jessen F, Rao ML, Maier W, Bjorkhem I, von Bergmann K, Heun R (2000) Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer\u2019s disease. Neuroreport 11:1959\u20131962","journal-title":"Neuroreport"},{"key":"9778_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneur.60.1.29","volume":"60","author":"A Papassotiropoulos","year":"2003","unstructured":"Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A, L\u00fctjohann D, Ghebremedhin E, Hegi T, Pasch T, Tr\u00e4xler M, Br\u00fchl A, Benussi L, Binetti G, Braak H, Nitsch RM, Hock C (2003) Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 60:29\u201335","journal-title":"Arch Neurol"},{"key":"9778_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/138920006776359257","volume":"7","author":"A Palot\u00e1s","year":"2006","unstructured":"Palot\u00e1s A, K\u00e1lm\u00e1n J (2006) Candidate susceptibility genes in Alzheimer\u2019s disease are at high risk for being forgotten\u2014they don\u2019t give peace of mind. Curr Drug Metab 7:273\u2013293","journal-title":"Curr Drug Metab"},{"key":"9778_CR27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2003.11.009","volume":"25","author":"AB Reiss","year":"2004","unstructured":"Reiss AB, Siller KA, Rahman MM, Chan ES, Ghiso J, de Leon MJ (2004) Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer\u2019s disease. Neurobiol Aging 25:977\u2013989","journal-title":"Neurobiol Aging"},{"key":"9778_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1096-8628(19980207)81:1<49::AID-AJMG10>3.0.CO;2-W","volume":"81","author":"AD Roses","year":"1998","unstructured":"Roses AD (1998) Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases. Am J Med Genet 81:49\u201357","journal-title":"Am J Med Genet"},{"key":"9778_CR29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2005.08.048","volume":"391","author":"N Shibata","year":"2006","unstructured":"Shibata N, Kawarai T, Lee JH, Lee HS, Shibata E, Sato C, Liang Y, Duara R, Mayeux RP, St George-Hyslop PH, Rogaeva E (2006) Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer\u2019s disease. Neurosci Lett 391:142\u2013146","journal-title":"Neurosci Lett"},{"key":"9778_CR30","doi-asserted-by":"crossref","first-page":"773.e1","DOI":"10.1016\/j.neurobiolaging.2005.03.029","volume":"27","author":"A Tedde","year":"2006","unstructured":"Tedde A, Rotondi M, Cellini E, Bagnoli S, Muratore L, Nacmias B, Sorbi S (2006) Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer\u2019s disease. Neurobiol Aging 27:773.e1\u2013773.e3","journal-title":"Neurobiol Aging"},{"key":"9778_CR31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archneur.60.4.510","volume":"60","author":"GL Vega","year":"2003","unstructured":"Vega GL, Weiner MF, Lipton AM, Von Bergmann K, L\u00fctjohann D, Moore C, Svetlik D (2003) Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurol 60:510\u2013515","journal-title":"Arch Neurol"},{"key":"9778_CR32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neulet.2004.07.020","volume":"369","author":"B Wang","year":"2004","unstructured":"Wang B, Zhang C, Zheng W, Lu Z, Zheng C, Yang Z, Wang L, Jin F (2004) Association between a T\/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer\u2019s disease in Chinese. Neurosci Lett 369:104\u2013107","journal-title":"Neurosci Lett"},{"key":"9778_CR33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2007.02.005","volume":"25","author":"F Wang","year":"2007","unstructured":"Wang F, Jia J (2007) Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer\u2019s disease in Chinese. Brain Res 25:34\u201338","journal-title":"Brain Res"},{"key":"9778_CR34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2010.12.008","volume":"489","author":"LZ Wang","year":"2011","unstructured":"Wang LZ, Tian Y, Yu JT, Chen W, Wu ZC, Zhang Q, Zhang W, Tan L (2011) Association between late-onset Alzheimer\u2019s disease and microsatellite polymorphisms in intron II of the human toll-like receptor 2 gene. Neurosci Lett 489:164\u2013167","journal-title":"Neurosci Lett"},{"key":"9778_CR35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jnr.10348","volume":"70","author":"K Yanagisawa","year":"2002","unstructured":"Yanagisawa K (2002) Cholesterol and pathological processes in Alzheimer\u2019s disease. J Neurosci Res 70:361\u2013366","journal-title":"J Neurosci Res"},{"key":"9778_CR36","doi-asserted-by":"crossref","first-page":"1924.e1","DOI":"10.1016\/j.neurobiolaging.2011.03.023","volume":"32","author":"JT Yu","year":"2011","unstructured":"Yu JT, Sun YP, Ou JR, Cui WZ, Zhang W, Tan L (2011) No association of toll-like receptor 2 polymorphisms with Alzheimer\u2019s disease in Han Chinese. Neurobiol Aging 32:1924.e1\u20131924.e3","journal-title":"Neurobiol Aging"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9778-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-012-9778-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9778-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:24:49Z","timestamp":1559442289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-012-9778-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,22]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["9778"],"URL":"https:\/\/doi.org\/10.1007\/s12031-012-9778-5","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,22]]}}}